Cytek to Participate in the 42nd Annual Cowen Health Care Conference

Rhea-AI Summary

FREMONT, Calif., Feb. 16, 2022 – Cytek Biosciences (Nasdaq: CTKB) announces its participation in the 42^nd Annual Cowen Health Care Conference. Management will engage in a fireside chat on March 9^th at 8:10 a.m. PT / 11:10 a.m. ET. Interested participants can access the live and archived webcast via the Investors section of Cytek's website.

Cytek is a leader in cell analysis solutions, utilizing its Full Spectrum Profiling™ technology for high-resolution and high-sensitivity analysis. Its platform includes the Aurora and Northern Lights™ systems, and products are primarily for research use.

FREMONT, Calif., Feb. 16, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced the company will be participating virtually in the upcoming 42^nd Annual Cowen Health Care Conference.

Cytek’s management is scheduled to participate in a fireside chat on Wednesday, March 9^th at 8:10 a.m. Pacific Time / 11:10 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: investors.cytekbio.com.

About Cytek Biosciences
Cytek Biosciences is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling™ (FSP™) technology. Cytek’s novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with exquisite sensitivity. Cytek’s FSP platform includes its core instruments, the Aurora and Northern Lights™ systems, its cell sorter, the Aurora CS, and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers. Cytek is headquartered in Fremont, California with offices and distribution channels across the globe.

Other than Cytek’s Northern Lights CLC system, which is available for clinical use in China and the European Union, Cytek’s products are for research use only – not for use in diagnostic procedures or for clinical purposes.

Cytek, Full Spectrum Profiling, FSP and Northern Lights are trademarks or registered trademarks of Cytek Biosciences, Inc.

Investor Relations Contact:
Carrie Mendivil/Alex Khan
Gilmartin Group LLC
investors@cytekbio.com 

Media Contact:
Stephanie Olsen
Lages & Associates
(949) 453-8080
stephanie@lages.com

FAQ

What event will Cytek Biosciences (CTKB) participate in?

Cytek Biosciences will participate in the 42^nd Annual Cowen Health Care Conference.

When is Cytek's fireside chat scheduled?

The fireside chat is scheduled for March 9^th at 8:10 a.m. Pacific Time / 11:10 a.m. Eastern Time.

How can I access Cytek Biosciences' presentation?

You can access the live and archived webcast of Cytek's presentation on their Investors website.

What technology does Cytek Biosciences utilize?

Cytek uses Full Spectrum Profiling™ (FSP™) technology, offering high-resolution and high-sensitivity cell analysis.

Are Cytek's products approved for clinical use?

Only Cytek's Northern Lights CLC system is available for clinical use in China and the European Union; the rest are for research use only.